Suchergebnisse - "Lote, Hazel"

PubPharm (28)

1

MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients

enthalten in: Frontiers in oncology | 2023

von Lote, H. | Mousoullou, F. | Vlachogiannis, G. | +14

2

Advances in immunotherapy for MMR proficient colorectal cancer

enthalten in: Cancer treatment reviews | 2022

von Lote, H. | Starling, N. | Pihlak, R. | +1

3

Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Lote, H. | Chau, I.

4

Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Lote, H. | Chau, I.

5

miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Anandappa, G. | Lampis, A. | Cunningham, D. | +24

6

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial

enthalten in: Cancer discovery | 2018

von Khan, K. | Cunningham, D. | Werner, B. | +33

CommentIn: Cancer Discov. 2018 Oct;8(10):1213-1215. - PMID 30279194

7

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study

enthalten in: Gut | 2018

von Khan, K. | Rata, M. | Cunningham, D. | +29

CommentIn: Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):566. - PMID 28831182

8

HER2 inhibition in gastro-oesophageal cancer : A review drawing on lessons learned from breast cancer

enthalten in: World journal of gastrointestinal oncology | 2018

von Lote, H. | Valeri, N. | Chau, I.

9

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

enthalten in: Science (New York, N.Y.) | 2018

von Vlachogiannis, G. | Hedayat, S. | Vatsiou, A. | +40

CommentIn: Cancer Discov. 2018 May;8(5):524. - PMID 29535134

10

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

enthalten in: Scientific reports | 2018

von Sclafani, F. | Chau, I. | Cunningham, D. | +19